Vergoeding 2017-2021 voor ATC-subgroep B01A : Antithrombotica
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| B01AA Vitamine k-antagonisten | 4.614.900 | 4.027.300 | 3.654.800 | 3.344.700 | 3.203.900 |
| B01AB Heparinegroep | 27.825.200 | 24.688.700 | 21.591.600 | 18.017.700 | 16.105.800 |
| B01AC Trombocytenaggregatieremmers excl heparine | 54.512.100 | 54.783.600 | 52.539.200 | 50.402.000 | 49.374.000 |
| B01AD Enzymen | 9.527 | 2.655 | . | 3.172 | 13.662 |
| B01AE Directe trombineremmers | 31.113.700 | 37.162.600 | 39.981.700 | 36.107.300 | 30.657.500 |
| B01AF Directe remmers van factor xa | 79.828.400 | 118.675.700 | 158.703.400 | 191.925.900 | 218.686.300 |
| B01AX Overige antithrombotica | 854.270 | 853.380 | 731.940 | 597.250 | 679.660 |
| Totaal | 198.758.097 | 240.193.935 | 277.202.640 | 300.398.022 | 318.720.822 |